ASCENT PHARMS INC FDA Approval ANDA 214957

ANDA 214957

ASCENT PHARMS INC

FDA Drug Application

Application #214957

Application Sponsors

ANDA 214957ASCENT PHARMS INC

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL600MG0GABAPENTINGABAPENTIN
002TABLET;ORAL800MG0GABAPENTINGABAPENTIN

FDA Submissions

UNKNOWN; ORIG1AP2021-10-01STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

ASCENT PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214957
            [companyName] => ASCENT PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"GABAPENTIN","activeIngredients":"GABAPENTIN","strength":"600MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"GABAPENTIN","activeIngredients":"GABAPENTIN","strength":"800MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/01\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-10-01
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.